First-in-Human trial launches for promising new prostate cancer pill
Disease control
Not yet recruiting
This is the first study in people to test the safety of a new oral drug called (R)-9bMS for advanced prostate cancer that has spread and stopped responding to standard hormone therapies. The main goal is to find a safe dose and see how well patients tolerate the medication. About…
Phase: PHASE1 • Sponsor: TechnoGenesys, Inc. • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC